X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
54
PharmaCompass offers a list of Dexamethasone Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dexamethasone Acetate manufacturer or Dexamethasone Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dexamethasone Acetate manufacturer or Dexamethasone Acetate supplier.
PharmaCompass also assists you with knowing the Dexamethasone Acetate API Price utilized in the formulation of products. Dexamethasone Acetate API Price is not always fixed or binding as the Dexamethasone Acetate Price is obtained through a variety of data sources. The Dexamethasone Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate, including repackagers and relabelers. The FDA regulates 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate supplier is an individual or a company that provides 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate active pharmaceutical ingredient (API) or 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate finished formulations upon request. The 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate suppliers may include 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate API manufacturers, exporters, distributors and traders.
click here to find a list of 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate active pharmaceutical ingredient (API) in detail. Different forms of 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate DMFs exist exist since differing nations have different regulations, such as 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate DMF submitted to regulatory agencies in the US is known as a USDMF. 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate USDMF includes data on 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate suppliers with USDMF on PharmaCompass.
A 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate CEP of the European Pharmacopoeia monograph is often referred to as a 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate Certificate of Suitability (COS). The purpose of a 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate to their clients by showing that a 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate CEP has been issued for it. The manufacturer submits a 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate CEP (COS) as part of the market authorization procedure, and it takes on the role of a 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate CEP holder for the record. Additionally, the data presented in the 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate DMF.
A 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate suppliers with NDC on PharmaCompass.
16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate GMP manufacturer or 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate GMP API supplier for your needs.
A 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate CoA (Certificate of Analysis) is a formal document that attests to 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate's compliance with 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate specifications and serves as a tool for batch-level quality control.
16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate CoA mostly includes findings from lab analyses of a specific batch. For each 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate EP), 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (16.alpha.-Methyl-9.alpha.-fluoroprednisolone 21-acetate USP).
Market Place
